Browsing by Subject "Gastric cancer"
Now showing items 1-4 of 4
-
CD1d expression and invariant natural killer T-cell numbers are reduced in patients with upper gastrointestinal cancers and are further impaired by commonly used chemotherapies
(2020)Esophageal and gastric cancers collectively cause over 1.1 million deaths annually and only 20-30% of patients respond favorably to current therapies. Cellular therapies using invariant natural killer T (iNKT) cells are ... -
Cooperation between chemotherapy and immunotherapy in gastroesophageal cancers
(2020)Gastroesophageal cancers (GOCs) represent some of the most common cancers globally and are linked with poor survival rates. The current standard of care includes multimodal chemotherapy, radiotherapy and surgery. However, ... -
The role and treatment potential of natural killer T (NKT) cells in patients with upper gastrointestinal cancers
(Trinity College Dublin. School of Medicine. Discipline of Immunology, 2019)Oesophageal adenocarcinoma (OAC), squamous cell carcinoma (SSC) and gastric cancers (GAC), collectively cause over 1.3 million deaths worldwide reported in 2018. Current therapeutic regimens focus on chemo-radiotherapy ... -
The role of vitamin D and UVB on the risk and survival of oesophageal and gastric cancer
(Trinity College Dublin. School of Medicine. Discipline of Public Health & Primary Care, 2018)The Role of Vitamin D and UVB on the Risk and Survival of Oesophageal and Gastric Cancer By Fiona O?Sullivan Background: Vitamin D is a fat-soluble vitamin which has many sources. Currently, there are numerous ways in ...
